Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Disease, Pulmonary

1-methyl-3-isobutylxanthine has been researched along with Disease, Pulmonary in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weishaar, RE1
Cain, MH1
Bristol, JA1
Crosswhite, P1
Sun, Z1

Reviews

1 review available for 1-methyl-3-isobutylxanthine and Disease, Pulmonary

ArticleYear
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets;

1985

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Disease, Pulmonary

ArticleYear
Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension.
    Hypertension (Dallas, Tex. : 1979), 2013, Volume: 61, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Acetophenones; Animals; Cold Temperature; Cyclic Nucleotide Phosphodies

2013